Jupiter Wellness

Jupiter Wellness, Inc. engages in the development of cannabidiol based medical therapeutics and wellness products. Its product line includes CaniSun, CaniSkin, and CaniDermRx. It operates through the following segments: sales and development of cannabidiol (CBD) based skin care and therapeutic products and sales of merchandise sold to theme parks segments.The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Safety Shot, Inc. is a wellness and dietary supplement company. It has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.

Aurora Innovation

ZW Data Action Technologies Inc.

Eos Energy Enterprises

Penny stocks to buy right now? Check out these 4 to watch.

Best Penny Stocks To Buy? 4 To Watch After HKD Stock Explodes

JUPITER, FL / ACCESSWIRE / September 15, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair, skin, and sexual health, announced today that it has published a shareholder letter and company update detailing recent progress and their renewed focus on science-backed product development. "We have had a great start to the year.

Jupiter Wellness Issues Shareholder Letter and Provides Corporate Update

JUPITER, FL / ACCESSWIRE / September 9, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair, skin, and sexual health, announced today the appointment of Dr. Skender Fani to its board of directors effective September 15, 2022. Dr. Fani will replace Dr. Hector Alila, who will be moving to the Company's Scientific Advisory Board.

Jupiter Wellness Appoints Dr. Skender Fani to Its Board of Directors

New Zoonicorn Branded Consumer Products From SRM Entertainment to Be Available Beginning Fall, 2022 JUPITER, FL / ACCESSWIRE / August 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that its SRM Entertainment division has entered into a multi-year global licensing agreement with Los Angeles-based Zoonicorn, the multiplatform animated preschool brand from Zoonicorn, LLC and Toonz Media Group. SRM Entertainment has entered into an agreement to use Zoonicorn with its proprietary Sip With Me children's cup line of products.

SRM Entertainment Announces Licensing Agreement with Toonz Media Group and Zoonicorn LLC for Pre-School Brand Zoonicorn

Minoxidil Booster Licensed to Taisho Pharmaceutical for the Japanese Market No Stingz Jellyfish Protectant SPF Sunscreen Launched $3,000,582 in Revenues for the Three Months Ended June 30, 2022 JUPITER, FL / ACCESSWIRE / August 16, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced financial results for the second quarter ended June 30, 2022, and provided an overview of recent operational highlights. Recent Highlights-Corporate In June 2022, Jupiter Wellness announced they licensed SULT1A1 minoxidil booster to Taisho Pharmaceutical Co. Ltd (TYO:4581) for the Japanese market.

Jupiter Wellness Reports Second Quarter 2022 Financial Results and Operational Highlights

Smurfs brand and characters to be featured on custom "Sip With Me" Product Lines JUPITER, FL / ACCESSWIRE / August 11, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that its SRM Entertainment division has entered into a multi-year licensing agreement with LAFIG Belgium for use of the Smurfs brand name and charcters to be featured on SRM's proprietary Sip With Me line of childrens hydration and table-top products. The Smurfs license was created by The Brand Liaison as licensing agent for SRM.

SRM Entertainment Announces Multi-Year SMURFS License

Benuvia Agrees to Pay $3 MM and Issue Capital Stock Representing 8.0% of their previously announced SPAC merger with Pono Capital Corp JUPITER, FL / ACCESSWIRE / July 26, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that it entered into a Forbearance and Settlement Agreement with Benuvia, Inc., formally Next Frontier Pharmaceuticals, a leading drug developer and manufacturer of active pharmaceutical ingredients. Under the terms of the Forbearance and Settlement Agreement, Jupiter Wellness will refrain from exercising the rights and remedies that they have as specified in the convertible note agreements unless a breach of the Forbearance and Settlement Agreement occurs.

Jupiter Wellness Announces Repayment Agreement with Benuvia, Inc., Formally Next Frontier Pharmaceuticals

Jupiter receives upfront payment plus double-digit royalties on revenues in 31 countries for clinically proven minoxidil (Rogaine®) products Minoxidil Booster and After Minoxidil Spray, and Photoci, a patented topical cream clinically proven to provide relief from psoriasis, vitiligo, and eczema JUPITER, FL / ACCESSWIRE / June 28, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it has signed an agreement with India-based companies Cosmofix Technology Pvt Ltd and Sanpellegrino Cosmetics Pvt Ltd for the manufacture, sale, and distribution of three proprietary products related to its recent acquisition of Ascent Clinical Research. Jupiter has received an upfront payment and is entitled to royalties of between 10-12% on revenues for the three products with guaranteed annual minimum royalty payments for the duration of the agreement in 31 countries in Asia and the Middle East including India, the Philippines, Malaysia, Kuwait, Morocco, and Saudi Arabia.

Jupiter Wellness Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Photoci(TM) Products

Taisho to introduce a minoxidil booster developed by Applied Biology to boost minoxidil efficacy for Androgenetic Alopecia patients that do not respond to minoxidil The minoxidil sulfotransferase enzyme booster (SULT1A1) was acquired by Jupiter Wellness in an acquisition of assets that included issued patents, patent applications, products, clinical trial results, and licensing agreements from Applied Biology JUPITER, FL / ACCESSWIRE / June 23, 2022 / Jupiter Wellness (NASDAQ:JUPW) and Taisho Pharmaceutical Co. Ltd (TYO:4581) today announced that Taisho Pharmaceutical has entered into a license agreement for Jupiter Wellness's minoxidil booster for the Japanese market. Minoxidil is the only US FDA-approved topical drug for the treatment of common hair loss (androgenetic alopecia).

Jupiter Wellness Licenses Minoxidil Booster to Taisho

JUPITER, FL / ACCESSWIRE / June 22, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Prof. Andy Goren, MD, and John McCoy, PhD have joined Jupiter Wellness as Chief Medical Officer and Vice President of R&D respectively.

Dr. Andy Goren and Dr. John McCoy Appointed to Senior Scientific Positions at Jupiter Wellness

Assets include issued patents, patent applications, products, clinical trial results, licensing agreements Applied Biology generated approximately $8 million in revenues and $3 million in EBITDA in 2021 (unaudited) Regulatory expertise with US FDA, EMA, KFDA (Korea), PMDA (Japan), ANVISA (Brazil), CFDA (China) JUPITER, FL / ACCESSWIRE / June 21, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced the acquisition of 100% of the assets of Applied Biology, Inc. a leading biotechnology company specializing in hair and skin science, for up to 4 million shares of Jupiter Wellness stock deliverable upon completion of certain milestones. Applied Biology is a developer of breakthrough drugs and medical devices for the treatment of skin and hair disorders.

Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science

JUPITER, FL / ACCESSWIRE / June 17, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the purchase and retirement of 2,433,894 common shares, which reduces the Company's outstanding common shares to 22,151,528, an approximate 10% reduction in shares outstanding. The Company previously announced a $5.0 million share buyback program.

Jupiter Wellness Announces the Retirement of Approximately 10% of its Outstanding Shares

JUPITER, FL / ACCESSWIRE / June 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that Paul Jones has joined Jupiter Wellness as Senior Project Manager. Paul joins Jupiter Wellness with over 20 years of experience building and directing operations, implementing improvements and overseeing projects in a wide range of industries.

Paul Jones Appointed as Senior Project Manager at Jupiter Wellness

JW-300 Demonstrated Efficacy in the Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo-Controlled Clinical Trial JUPITER, FL / ACCESSWIRE / May 4, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) will present data for Jupiter's JW-300, a cannabidiol topical treatment for first degree burns, at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference to take place May 11-15, 2022 in Nashville, Tennessee. In a clinical trial of 36 patients, a controlled area of skin was exposed to UV irradiation.

Jupiter Wellness' to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference

IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS OF ASCENT CLINICAL RESEARCH JUPITER, FL / ACCESSWIRE / April 27, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it has concluded an Asset Purchase Agreement with Ascent Clinical Research, Inc. through which it has acquired certain clinical assets including clinical trial research contracts worth $3 million in annual revenues for a purchase price of 5% royalties on future net revenues generated by the assets. "This strategic asset purchase agreement adds immediate revenues to Jupiter in Q2 2022 and contributes positively towards EBITDA with no upfront cash or stock acquisition cost to our company.

Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter

JUPITER, FL / ACCESSWIRE / April 18, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that it has appointed three sales and marketing executives to its team to drive sales of its science-backed proprietary brands and products. Over the past two years, Jupiter has built a portfolio of award-winning wellness brands including CaniSun, fitCBD, Jack, Wellness CBD 1937, Black Belt CBD, and Felix Ambrosia, as well prescription therapeutics such as Photosil that have been featured in numerous media outlets including the Today Show, CNN, ABC, CBS, Animal Planet, AdWeek, Bloomberg, The Washington Post, Vogue, BuzzFeed, and Forbes.

Jupiter Wellness Appoints E-Commerce & Marketing Team to Drive Sales of its Growing Portfolio of Proprietary Health and Wellness Brands

Exclusive Worldwide Rights to Patented Shark Repellent Technologies for the Sun and Skin Market Licensed From Shark Defense Technologies, the Leader in Its Field Featured in Numerous Media Outlets Including Discovery Channel's Shark Week and Animal Planet View Discovery Channel Videos on the Shark Repellent Technology Here: https://youtu.be/Hqp04gdAXyk and Here: https://youtu.be/PM0YTlbx1qg JUPITER, FL / ACCESSWIRE / April 7, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced the upcoming launch of CaniSun for Shark Defense™, the latest addition to the Company's reef-friendly sunscreen line. Through a licensing agreement with Shark Defense Technologies LLC, the leading researcher of chemical, electrochemical, and magnetic shark repellents, Jupiter has the exclusive worldwide rights to patents, formulas, and production methods for shark repellent technologies for use in sun and skincare products.

Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents

Authored by an International Group of Leading Dermatology Researchers and Clinicians Who Conducted the Studies JUPITER, FL / ACCESSWIRE / April 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the safety and efficacy of JW-100 its proprietary lotion formulation for the treatment of atopic dermatitis (eczema) in the Journal of Cosmetic Dermatology, Vol. 21, Issue 4, April 2022, pp: 1647-1650.

Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology

Data expected Q1 2022 on efficacy of JW-200 to clear AK lesions, a common form of pre-cancerous growth that left untreated can lead to cancer in up to 15% of patients JUPITER, FL / ACCESSWIRE / February 18, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it has completed recruitment in its clinical trial of JW-200 for the treatment of actinic keratosis (AK), a common form of pre-cancerous growths that typically present as thick scaly lesions on sun exposed skin. If left untreated, up to 15.1% of patients with 10 or more AK lesions will develop keratinocyte carcinoma.

Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis

JUPITER, FL / ACCESSWIRE / February 15, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that its merger partner Next Frontier Pharmaceuticals' Executive Chairman Shannon Soqui was interviewed on Benzinga's All Access 6 Emerging Growth Companies To Watch In 2022 program which can be viewed: HERE Jupiter previously announced its definitive merger agreement with Next Frontier. The merger has been approved by the boards of both companies and is pending shareholder and regulatory approval.

Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga

Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINK JUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced that its CEO Brian John and Next Frontier Pharmaceuticals' Executive Chairman Shannon Soqui were interviewed on SNN Network. The interview titled "Jupiter Wellness Talks Merger with Next Frontier Pharmaceuticals, Strategic Plan and Next Steps" can be viewed: HERE Jupiter previously announced its definitive merger agreement with Next Frontier.

Jupiter Wellness' CEO Brian John & Next Frontier's Executive Chairman Shannon Soqui Interviewed on SNN Network

Next Frontier Pharmaceuticals is pursuing FDA 505(b)(2) fast-track approval with its previously FDA approved oral dronabinol (THC) solution Next Frontier Pharmaceuticals has completed a pre-IND meeting with the FDA, and intends to commence Phase II Clinical Trials in the 2H 2022; industry research and studies support targeted efficacy endpoints Alzheimer's Disease Agitation (Agit-AD) is estimated to affect more than four million seniors in the U.S. with no current FDA approved pharmacotherapies available JUPITER, FL and ROUND ROCK, TX / ACCESSWIRE / February 1, 2022 / Jupiter Wellness , Inc. (NASDAQ:JUPW), today announces that its merger partner, Next Frontier Pharmaceuticals, Inc., a leading drug developer focused on pharmaceutical cannabinoid APIs, plans to pursue an IND for its oral dronabinol solution for the treatment of Alzheimer's Disease Agitation (Agit-AD). Next Frontier Pharmaceuticals' oral dronabinol solution CII is approved as SYNDROS® by the FDA for the treatment of chemotherapy-induced nausea and vomiting in cancer patients and loss of appetite in AIDS patients who have lost weight.

Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation

Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market price JUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it its board of directors approved a $5.0 million share buyback program which expires on June 30, 2022 (the "Share Buyback Program"). Under the Share Buyback Program, shares of the Company's common stock may be repurchased periodically in open market or privately negotiated transactions.

Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program

Jupiter Wellness, Inc. (NASDAQ:JUPW) revealed plans Monday to dividend its wholly-owned subsidiary, SRM Entertainment to its stockholders with Jupiter's merger with Next Frontier Pharmaceuticals, Inc. Each Jupiter Wellness stockholder will be entitled to approximately one share of SRM Entertainment common stock for every four shares of Jupiter Wellness common stock owned. The transaction is expected to be completed in the coming four months, assuming regulatory and stockholder approval.

Jupiter Wellness To Dividend SRM Entertainment Subsidiary To Its Stockholders.

SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier Pharmaceuticals JUPITER, FL / ACCESSWIRE / January 24, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it intends to dividend its wholly-owned subsidiary, SRM Entertainment to its stockholders in conjunction with Jupiter Wellness' merger with Next Frontier Pharmaceuticals, Inc. Each Jupiter Wellness stockholder will be entitled to approximately one share of SRM Entertainment common stock for every four shares of Jupiter Wellness common stock owned. The transaction is expected to be completed in the next four months assuming regulatory and stockholder approval.

News for Jupiter Wellness Stock (JUPW)